Time to improve the reporting of harms in randomized controlled trials

Daniela R. Junqueira; Rachel Phillips; Liliane Zorzela; Su Golder; Yoon K. Loke; David Moher; John P A Ioannidis; Sunita Vohra

doi:10.1016/j.jclinepi.2021.04.020

Related publications

Article2004

Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement

John P A Ioannidis

Article2023

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials

Daniela R. Junqueira, Liliane Zorzela, Su Golder, Yoon K. Loke, Joel Gagnier, Steven A. Julious, Tianjing Li, Evan Mayo‐Wilson, Ba Pham, Rachel Phillips, Pasqualina Santaguida, Roberta W. Scherer, Peter C Gøtzsche, David Moher, John P A Ioannidis, Sunita Vohra, Stephen Evans, Ann Fonfa, T. Lang, Elizabeth Loder, Laura Weeks

Letter2002

Reporting the clinical importance of randomized controlled trials.

David Moher, Douglas G. Altman, Kenneth F. Schulz

Article1994

A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group

Erik Andrew, Aslam H. Anis, Mildred K. Cho, Mike Clarke, David T. Felson, Peter C Gøtzsche, Richard E. Greene, Alejandro R. Jadad, Wayne B. Jonas, Terry P. Klassen, Paul Knipschild, Andreas Laupacis, Curtis L. Meinert, David Moher, Graham Nichol, Andy Oxman, Marie-France Penman, Stuart Pocock, Joan Reisch, David L. Sackett, Kenneth F. Schulz, Judy Snider, Peter Tugwell,

Article1998

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

Colin B. Begg, Mildred K. Cho, Susan Eastwood, Richard Horton, David Moher, Ingram Olkin, Roy M. Pitkin, Drummond Rennie, Kenneth F. Schulz, David L. Simel, Donna F. Stroup